SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to an after-hours dip following earnings, despite strong revenue growth, as investors react to increased AI spending plans and a one-time tax charge. The community is debating whether this presents a buying opportunity, focusing on the company's long-term potential in AI and the non-recurring nature of the tax impact. Discussions also involve comparisons to other tech giants and the potential for a market rebound.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as it approaches the $200 mark, fueled by optimism surrounding its AI capabilities and a potential Nvidia partnership. Community members are actively discussing the stock's valuation, potential for a stock split, and upcoming earnings. Sentiment is highly bullish, with some debating whether to lock in gains or hold for further upside.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors analyze its AI spending and recent earnings, with community members debating the impact of OpenAI investments on profitability. Discussions also focus on Azure's growth and its competitive positioning relative to other cloud providers and the potential for upgrades and target increases this week. Some traders are pointing out Cybersecurity concerns in light of recent AI spending.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending downwards amid concerns about the company's exposure to subprime auto loans and recent bankruptcies in the auto lending sector. The community is discussing the potential impact on Carvana's earnings and questioning the sustainability of its business model. Additionally, some investors are pointing to the company's high valuation and potential conflicts of interest as reasons for concern.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle's stock is trending due to a significant after-hours drop following concerns over same-store sales and demand in their recent earnings report. The community is discussing the impact of portion sizes, pricing, and overall value on consumer traffic, with some feeling priced out while others see an overreaction and buying opportunity. Discussions also include comparisons to competitors like CAVA and the potential for a leadership change.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around upcoming milestones, including a coin burn at 3000 watchers, and airdrop at $2.5M market cap. Discussions highlight the dev team's commitment, utility-backed buybacks, and new articles from Broke Perspective. The community is expressing bullish sentiment, emphasizing organic growth and long-term potential on the Solana blockchain.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as investors weigh the potential impact of Trump's upcoming meeting with Xi amid mixed earnings from major tech companies. Community discussions revolve around the possibility of a 'China deal' and its effects on the market, while some express concerns about overbought conditions and potential market corrections. Talk of nuclear weapon testing adds another layer of uncertainty.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending after crushing Q3 earnings, with retail traders now eyeing the stock as the next potential $4 trillion giant. The community is actively discussing the company's AI advancements, cloud growth, and potential to reach $300 soon. Some are noting that Google remains undervalued compared to peers like Apple and Microsoft, while others speculate about the impact of a potential Trump-Xi deal.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv ($FI) is trending due to a significant drop following lowered earnings guidance and a leadership shakeup, sparking debates about a potential oversold bounce. The community is discussing the new CEO's statements on past management and the company's valuation, with some seeing it as a buying opportunity given the low P/E ratio. Technical analysis indicators like RSI are also being closely watched for signs of a reversal.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to potential short squeeze and high after-hours momentum, with the community noting its low float and comparing it to previous runners. Bullish sentiment is fueled by speculation of a premarket gap up and potential for significant near-term gains. Some traders caution about potential risks associated with pump and dump schemes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock?

PROKIDNEY CP (PROK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Momentum Stocks to Buy for July 17th

PROK, ROKU and PHAR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 17, 2025.

New Strong Buy Stocks for July 17th

PHAR, ROKU, PROK, MAG and KRP have been added to the Zacks Rank #1 (Strong Buy) List on July 17, 2025.

ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy?

Does ProKidney Corp. (PROK) have what it takes to be a top stock pick for momentum investors? Let's find out.

PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study

Shares of ProKidney jump 515% after its kidney cell therapy shows strong efficacy in a Phase II diabetes-related CKD study.

Shares of ProKidney surged more than 500% on Tuesday following upbeat results from its Phase 2 REGEN-007 study and a price target upgrade from Citi.&nbsp;The company is developing rilparencel, an autologous cellular therapy aimed at slowing kidney function decline in patients with chronic kidney disease (CKD) and diabetes.Citi raised its price target to $9 from $6 and maintained a ‘Buy’ rating, saying the early data “exceeded expectations.”&nbsp;The firm increased the probability of success for the program to 60%, citing statistically significant efficacy seen in Group 1 of the trial, which may support accelerated approval in Phase 3 subject to FDA feedback.The REGEN-007 study showed that kidney function decline was reduced by 78% in group 1 after rilparencel treatment.&nbsp;Patients who received two injections approximately three months apart experienced an improvement in their annual eGFR slope from -5.8 to -1.3 mL/min/1.73 m², representing a statistically and clinically meaningful difference.However, Bank of America was more cautious, reiterating its ‘Underperform’ rating and $1 price target.&nbsp;The firm flagged the absence of a sham comparator, lack of a conference call to discuss the data, and regulatory ambiguity. It stated that the stock’s sharp rally “looks overdone,” especially given that detailed data are likely to be withheld for a future medical meeting.ProKidney reported that no serious side effects were observed in the trial, and the safety results were consistent with earlier studies.&nbsp;Rilparencel already holds RMAT status from the FDA and is also being tested in a larger Phase 3 trial called PROACT 1.&nbsp;The company noted that early signals from REGEN-007 reinforce previously observed efficacy trends in high-risk patient subgroups.On Stocktwits, retail sentiment for <a href="https://stocktwits.com/symbol/PROK">ProKidney</a> was ‘extremely bullish’ amid ‘extremely high’ message volume.One user anticipated strong momentum ahead, saying they were “thinking 100% gain tomorrow.”<stembedurl>https://stocktwits.com/MarketMana/message/620282357</stembedurl>Another poster struck a more cautious but optimistic tone, noting that while they’d “love for this ticker and its well-deserving product [to have] a double-digit run,” biotech stocks often see profit-taking after big moves.&nbsp;They said short sellers could enter soon but saw long-term potential, saying, “If Phase III pans out and it gets FDA approval, it could make you a millionaire.”<stembedurl>https://stocktwits.com/nomendivitiae/message/620278285</stembedurl>ProKidney’s stock has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

ProKidney (PROK) is developing rilparencel, an autologous cellular therapy aimed at slowing kidney function decline in patients with chronic kidney disease/ Photo credit: Getty Images

ProKidney Stock Skyrockets On Positive Trial Data; Citi Sees 60% Chance Of Success

The treatment, rilparencel, showed a 78% improvement in kidney function decline in one dosing group, with no serious safety issues reported, supporting its ongoing evaluation in a larger Phase 3 trial.

Equity

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm PR Newswire NEW YORK, Jan. 31, 2025 NEW YORK, Jan. 31, 2025...

Futures Drop Ahead Of CPI, FOMC; Euro Slumps After Weekend Election Shock

Futures Drop Ahead Of CPI, FOMC; Euro Slumps After Weekend Election Shock

 US equities were poised for modest losses to start the week after underlying indexes hit a new all time high on...

ProKidney appoints Ulrich Ernst as EVP, technical operations

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

Current Price	$3.10
Prev Close	$3.04
Open	$3.00
Dividend Yield	0.00%
50-Day Moving Average	$2.72
Beta	2.23
Avg. Volume	2.26M
PE Ratio	-5.49

52-Week High	$7.13
52-Week Low	$0.4603
Market Capitalization	$418.48M
EPS (Annual)	-$0.6249
Price to Book	-0.41
Revenue Per Employee	$372.55
Enterprise Value/EBITDA	N/A

PROK
ProKidney Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PROK News

PROKProKidney Corp